The evolving role of regulatory T cells in pulmonary diseases: immunomodulatory mechanisms and translational directions revealed by bibliometric analysis - Scorecard - MDSpire
Advertisement
The evolving role of regulatory T cells in pulmonary diseases: immunomodulatory mechanisms and translational directions revealed by bibliometric analysis
Clinical Scorecard: The Changing Function of Regulatory T Cells in Lung Diseases: Insights into Immunomodulatory Mechanisms and Future Directions from Bibliometric Analysis
At a Glance
Category
Detail
Condition
Pulmonary Diseases
Key Mechanisms
Regulatory T cells (Tregs) and their role in immune homeostasis and disease progression.
Target Population
Patients with various pulmonary diseases, including asthma, COPD, and lung cancer.
Care Setting
Research and clinical settings focusing on immunology and respiratory medicine.
Key Highlights
Tregs are crucial for maintaining pulmonary immune balance.
Dysregulation of Tregs is linked to poor outcomes in lung diseases.
Research on Tregs has evolved into multiple interconnected hotspots.
China has emerged as the leading country in Treg research since 2021.
Emerging therapeutic strategies include targeting Tregs and the tumor microenvironment.
Guideline-Based Recommendations
Diagnosis
Assess Treg levels and function in patients with pulmonary diseases.
Management
Consider immunotherapy targeting Tregs in treatment plans for lung diseases.
Monitoring & Follow-up
Monitor Treg populations and their functional status in patients.
Risks
Dysregulation of Tregs can lead to exacerbation of pulmonary diseases.
Patient & Prescribing Data
Individuals with chronic inflammatory lung diseases and cancer.
Targeting Tregs may offer new avenues for precision immunotherapy.
Clinical Best Practices
Utilize bibliometric analysis for understanding research trends in Treg studies.
Incorporate findings on Tregs into clinical research and practice.
